Cargando…
Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608133/ https://www.ncbi.nlm.nih.gov/pubmed/32719534 http://dx.doi.org/10.1038/s41585-020-0361-5 |
| _version_ | 1783604777976856576 |
|---|---|
| author | Gupta, Shilpa Kamat, Ashish M. |
| author_facet | Gupta, Shilpa Kamat, Ashish M. |
| author_sort | Gupta, Shilpa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7608133 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76081332020-11-05 Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good? Gupta, Shilpa Kamat, Ashish M. Nat Rev Urol Author Correction Nature Publishing Group UK 2020-07-27 2020 /pmc/articles/PMC7608133/ /pubmed/32719534 http://dx.doi.org/10.1038/s41585-020-0361-5 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Author Correction Gupta, Shilpa Kamat, Ashish M. Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good? |
| title | Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good? |
| title_full | Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good? |
| title_fullStr | Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good? |
| title_full_unstemmed | Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good? |
| title_short | Author Correction: NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good? |
| title_sort | author correction: nice’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good? |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608133/ https://www.ncbi.nlm.nih.gov/pubmed/32719534 http://dx.doi.org/10.1038/s41585-020-0361-5 |
| work_keys_str_mv | AT guptashilpa authorcorrectionnicesrejectionofpembrolizumabforplatinumrefractoryurothelialcarcinomaisthereagreatergood AT kamatashishm authorcorrectionnicesrejectionofpembrolizumabforplatinumrefractoryurothelialcarcinomaisthereagreatergood |